<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02348099</url>
  </required_header>
  <id_info>
    <org_study_id>H14-02461</org_study_id>
    <nct_id>NCT02348099</nct_id>
  </id_info>
  <brief_title>Ultrasound Detection and Characterization of Subclinical Hypertrophy in Diabetes</brief_title>
  <official_title>Ultrasound Guided Detection and Characterization of Subclinical Lipohypertrophy in Type 1 and Type 2 Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study to enroll 100 people to assess the incidence of lipohypertrophy as
      detected with ultrasound and its impact on glycemic variability.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lipohypertrophy is a well documented phenomenon in patients with diabetes in which
      hypertrophy and differentiation of adipocytes occurs in the dermal reticular layer at the
      sites of subcutaneous insulin injection. Currently, lipohypertrophy is assessed by palpating
      insulin injection sites. The detection on early, non palpable (subclinical) lipohypertrophy
      remains difficult in the clinical setting. Recent studies have identified distinct
      ultrasonographic features of hyperechogenicity in areas of adipose tissue consistent with
      clinical evidence of lipohypertrophy at insulin injection sites, and have detected changes
      int he thickness of subcutaneous tissue where not clinically evident in population of
      patients with type 1 diabetes. Lipohypertrophy can adversely affect glycemic control.
      Injecting into lipohypertrophic areas leads to poor absorption and the need for increasing
      doses of insulin.

      In this study study participants will undergo an assessment for lipohypertrophy during a
      scheduled visit at the VGH Diabetes Centre. A Diabetes Nurse will assess lipohypertrophy by
      palpation according to the FIT Protocol. A second diabetes nurse who was not present at the
      palpation will assess insulin injection sites for lipohypertrophy by ultrasound using a
      linear probe.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of Subclinical Lipohypertrophy</measure>
    <time_frame>Assessed one time only at the time of clinic visit</time_frame>
    <description>Lipohypertrophy seen on ultrasound but not felt by palpation</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Diabetes</condition>
  <condition>Lipohypertrophy</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>Abdomen scanned with portable ultrasound to determine presence of subclinical lipohypertrophy.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        People age 19 and over with type 1 or type 2 diabetes who take insulin to manage their
        diabetes.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  19 years of age or older

          -  Type 1 or Type 2 diabetes

          -  Using insulin to manage diabetes for at least 2 years

        Exclusion Criteria:

          -  Using insulin pumps, insulin secretagogues, Glucagon-Like Peptide-1 (GLP-1) agonists
             to manage diabetes

          -  Use of immunosuppressant agents

          -  Women who are pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Graydon Meneilly, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Boris Feldman</last_name>
    <phone>604-875-5115</phone>
    <email>boris.feldman@vch.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boris Feldman</last_name>
      <phone>604-875-5115</phone>
      <email>boris.feldman@vch.ca</email>
    </contact>
    <investigator>
      <last_name>Graydon S Meneilly, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jordanna Kapeluto, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Breay Paty, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Silvia Chang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 21, 2015</study_first_submitted>
  <study_first_submitted_qc>January 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2015</study_first_posted>
  <last_update_submitted>January 16, 2018</last_update_submitted>
  <last_update_submitted_qc>January 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Graydon Meneilly</investigator_full_name>
    <investigator_title>Professor, UBC Department of Medicine</investigator_title>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Lipohypertrophy</keyword>
  <keyword>Ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

